Workflow
JBG SMITH: Sell Now, Maybe Buy Later
Seeking Alpha· 2025-06-11 12:19
Office REITs were one of the main losers of REIT earnings season , according to Hoya Capital, the leading source for sector-level REIT analysis. After a very strong Q4, office leasing volumes for Q1 2025 were disappointing. Rent spreads andAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compen ...
Telos Corporation Secures Multi-Million Dollar Contract Renewal with U.S. Air Force
Globenewswire· 2025-06-11 12:15
U.S. Air Force looks to Xacta for critical automation and training solutionsASHBURN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced a contract extension with the U.S. Air Force to help meet complex compliance requirements with Telos’ flagship cyber governance, risk and compliance (GRC) platform, Xacta®. The Company secured a $3.7 million option ...
Brera Holdings PLC (Nasdaq: BREA) and Toronto Blizzard Grassroots Soccer Partnership Targets Youth Sports, an Estimated $69 Billion Industry by 2030
Globenewswire· 2025-06-11 12:15
Worth $37.5B in 2022, Youth Sports are Projected to Hit $69.4B by 2030 According to Profluence.com, with Sports Tourism’s Total Economic Impact $91.8B in 2021 Joe Parolini is the Owner and Coach of Toronto Blizzard Joe Parolini is the Owner and Coach of Toronto Blizzard Joe Parolini is the Owner and Coach of Toronto Blizzard Dublin, Ireland; Naples, Italy; and Toronto, Canada, June 11, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based intern ...
TSLA, INTC and PLTR Forecast – Stocks Continues to See Interest in the USA
FX Empire· 2025-06-11 12:08
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Dave & Buster's Q1 Earnings Simply Weren't Good Enough
Seeking Alpha· 2025-06-11 12:08
Dave & Buster's (NASDAQ: PLAY ) posted first quarter earnings Tuesday evening, and the stock is flying off of the report. Shares had been in a nasty downtrend into the April low, but have now recovered much of the previous losses, withJosh Arnold has been covering financial markets for a decade, utilizing a combination of technical and fundamental analysis to identify potential winners early on in their growth cycles. Josh's focus is mainly on growth stocks. His goal is efficient and profitable use of capit ...
Will Warner Bros. Discovery's Split Produce Double the Upside?
MarketBeat· 2025-06-11 12:06
Warner Bros. Discovery TodayWBDWarner Bros. Discovery$10.01 +0.48 (+5.04%) 52-Week Range$6.64▼$12.70Price Target$12.17Add to WatchlistRecent volatility in Warner Bros. Discovery NASDAQ: WBD stock is tied directly to a landmark strategic pivot. Since its formation in April 2022, the entertainment sector giant has traded at what many analysts have called a conglomerate discount, where the combined company's stock is valued for less than the sum of its individual parts. In a decisive move to address this, the ...
New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis
Prnewswire· 2025-06-11 12:05
TREMFYA ® demonstrated two and a half times greater ability to inhibit joint structural damage versus placebo in the Phase 3b APEX studyMore than 40% of TREMFYA®-treated patients across both dose groups achieved ACR50 at Week 24Improvement in both joint and skin symptoms reinforce TREMFYA® as a first-line treatment option with a proven safety profile for adults with active psoriatic arthritis BARCELONA, June 11, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced findings from the Phase 3b AP ...
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma
Globenewswire· 2025-06-11 12:05
In Patients Receiving a Minimum of 55 mCi an Average 5.4 Months of PFS was Observed: Twice the Reported 2.25 MedianFLORHAM PARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced initial results as of June 10, 2025, from the CLOVER-2 Phase 1 clinical trial evaluating iopofosine I 131 in relapsed/refractory pediatric high-grade glioma ...
ETFs to Buy as IBM Launches Fault-Tolerant Quantum PC
ZACKS· 2025-06-11 12:01
IBM (IBM) has announced a bold step forward in the quantum computing race with Starling, the world’s first large-scale fault-tolerant quantum computer. Slated for release in 2029, Starling will be housed in IBM’s newly established quantum data center in upstate New York. According to IBM, the system will perform 20,000 times more operations than current quantum machines, as quoted on Yahoo Finance.Why Fault Tolerance MattersThe breakthrough feature of Starling is its ability to operate without errors. This ...
Vera Bradley Announces First Quarter Fiscal Year 2026 Results
Globenewswire· 2025-06-11 12:01
First quarter consolidated net revenues totaled $51.7 million Financial condition remains strong with $86 million in liquidity and no debt FORT WAYNE, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced its financial results for the first quarter of the fiscal year ending January 31, 2026 (“Fiscal 2026”). First Quarter Comments Jackie Ardrey, Chief Executive Officer commented, “Our first quarter results were disappointing as top line and profitability tre ...